Modified Release Oral Formulation
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
CytokineticsSOUTH SAN FRANCISCO, CA
1 program1
Omecamtiv Mecarbil Matrix F1 FormulationPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CytokineticsOmecamtiv Mecarbil Matrix F1 Formulation
Clinical Trials (1)
Total enrollment: 544 patients across 1 trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
Start: Feb 2013Est. completion: Aug 2015544 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space